PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?

Journal Title: Pancreas – Open Journal - Year 2018, Vol 2, Issue 1

Abstract

Programmed cell death protein 1 (PD-1), a member of the CD28 family, is an immune-checkpoint receptor expressed on a variety of immune cells, such as T-cells, monocytes, B-cells, dendritic cells, and tumor-infiltrating lymphocytes (TILs).1 PD-1 major role is to limit the activity of T-cells in peripheral tissues at the time of an inflammatory response to constrain autoimmunity and tissue damage.1,2 Engagement of PD-1 by one of its two known ligands (PD-L1 and PD-L2) inhibits kinases involved in immune cell activation.2 Interestingly, PD-1 has an opposite function in Treg lymphocytes.3

Authors and Affiliations

Nicoletta Gagliano

Keywords

Related Articles

Recurrent Acute Pancreatitis: Dangerous Etiology?

Acute pancreatitis (AP) is a disorder clinically characterized by upper abdominal pain and elevated levels of pancreatic enzymes in the blood.1 After an initial evaluation, up to 10-30% of patients with AP are diagnosed...

Effects of Obesity and Diabetes on Beta-Cell Mass in Japanese

The prevalence of type 2 diabetes mellitus (T2DM) continues to increase all over the world. T2DM is characterized by insulin resistance and β-cell dysfunction. Recent studies have shown that β-cell dysfunction, but not i...

Pancreas: Do All Roads Lead to Mitochondria?

Over several millions of years of evolution, mitochondria have transformed into specialized organelles. Today, they cannot live outside the cell nor can the host cell live without them, resulting in a symbiotic relations...

Nutritional Support of Patients With the Abdominal Compartment Syndrome During Severe Acute Pancreatitis

There is growing evidence in the literature that development of Abdominal Compartment Syndrome (ACS) in patients with Severe Acute Pancreatitis (SAP) has a strong impact on the course of disease. Incidence of ACS in pati...

β-cell Heterogeneity: The Key to β-cell Replacement Therapy

Cellular heterogeneity is crucial for organisms to adapt to their environmental changes. It provides the morphological, functional and molecular diversity that allows tissues and organs to respond to stressors and mainta...

Download PDF file
  • EP ID EP556740
  • DOI 10.17140/POJ-2-e007
  • Views 176
  • Downloads 0

How To Cite

Nicoletta Gagliano (2018). PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?. Pancreas – Open Journal, 2(1), 5-7. https://europub.co.uk/articles/-A-556740